<DOC>
	<DOCNO>NCT00801463</DOCNO>
	<brief_summary>The purpose study assess efficacy prednisone tripterygium wilfordii treat Focal Segmental Glomerulosclerosis ( FSGS ) .</brief_summary>
	<brief_title>Prednisone Plus Tripterygium Wilfordii Treatment Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis</brief_title>
	<detailed_description>Primary FSGS lead cause end stage renal disease adult , complete loss kidney function 50 % patient 10 year . Steroids , currently use treat disease , effective part patient . Over past decade , number study report therapeutic efficacy treatment high-dose 6mo prednisone patient FSGS . These study show total effective rate around 50 % . But therapy take side effect prednisone . Except study , recent study suggest Tripterygium Wilfordii may effective passive Heymann nephritis , podocyte injury nephrosis rat induce puromycin aminonucleoside , . FSGS podocytepathy . There no-data Prednisone Tripterygium Wilfordii treatment Chinese adult patient idiopathic FSGS .</detailed_description>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Glomerulosclerosis , Focal Segmental</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Age 1860 year onset sign symptom FSGS Urine protein ≥ 3.5 g/24 h Estimated glomerular filtration rate ( GFR ) ≥ 40 ml/min/1.73 m2 , serum creatinine &lt; 2.5mg/dl Biopsy confirm idiopathic FSGS ( include subtypes ) Willingness follow clinical trial protocol , include medication , baseline followup visit procedure Secondary FSGS Prior therapy sirolimus , Cyclosporine , MMF , azathioprin , cytoxan , chlorambucil , levamisole , methotrexate , nitrogen mustard last 90 day Active/serious infection Malignancy Previously diagnose diabetes mellitus type 1 2 , abnormal carbohydrate tolerance Peripheral white blood cell &lt; 3000/ul Clinical evidence cirrhosis chronic active liver diseases History significant gastrointestinal disorder Allergy study medication , Inability consent/assent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Focal Segmental Glomerulosclerosis</keyword>
	<keyword>Prednisone</keyword>
	<keyword>Tripterygium Wilfordii</keyword>
</DOC>